NOI to Sole Source to Qiagen for maintenance and service contract

The National Institutes of Health (NIH) issued a Notice of Intent for a sole-source, firm fixed-price contract with Qiagen LLC to provide preventative maintenance and service for proprietary laboratory instruments currently onsite at their Bethesda, Maryland facility. Qiagen LLC is uniquely qualified as the sole manufacturer and authorized service provider for critical equipment including the QIAcuity One, 5plex Instrument, two QIAgility instruments, and the QIAsymphony SP system. Due to the proprietary nature of the technology and exclusive rights held by Qiagen for maintenance and repair, no other vendors are authorized or capable of performing these services, underpinning the justification for a non-competitive award under FAR Part 13.106-1(b)(1), which permits simplified acquisition procedures for limited sources. The contract focuses on ongoing preventative maintenance activities classified under Product Service Code J066, with performance exclusively at the NIH’s Bethesda location. The NOI does not specify pricing, contract duration, or detailed performance timelines, reflecting its status as a presolicitation rather than a formal solicitation. There is no inclusion of typical contract clauses, evaluation factors, packaging and marking requirements, or representations and certifications within the notice, consistent with the streamlined procurement approach. Interested parties are invited to submit expressions of interest or capability by email to the designated NIH Contract Specialist by the stated deadline. The documentation emphasizes the non-competitive nature of the procurement, the exclusive vendor status of Qiagen, and the requirement for specialized maintenance aligned with manufacturer protocols for high-value, sophisticated laboratory instrumentation used in NIH facilities.